drugset
drugset / Trial / NCT04362384

Topical Vitamin E Ovules for the Treatment of Hemorrhoids

NCT04362384 ↗

Phase 3 Unknown 120 enrolled Hospital General Universitario Elche
RandomizedParallel-groupSingle-blindTreatment

Summary

Patients with hemorrohoids grade II and III were included. Patients were randomized into 2 groups: * Experimental group: Patients will receive a treatment with vitamin E ovules, which must be placed inside the annus * Control group: Patients will receive a treatment with corticoid ointment, with endoanal application Bleeding, pain and stinging will be evaluated 14 days after beginning the treatment.

Timeline

Start
2020-05-01
Primary completion
2020-10-30
Completion
2020-10-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisolone Other / unclassified — Rectal
Subject Vitamin E Other / unclassified 1 unknown Rectal

Indications

No indication recorded.